NC
AVNS

nVerses Capital’s Avanos Medical AVNS Stock Holding History

nVerses Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,100
Closed -$21.9K – 1004
2024
Q2 		$21.9K Buy
+1,100
New +$21.4K 0.01% 775

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

nVerses Capital's AVNS Position: Q3 2024 in Review

nVerses Capital sold out of Avanos Medical (AVNS) in Q3 2024, closing a stake of 1,100 shares — an estimated $21.9K sold.

nVerses Capital first reported a position in AVNS in Q2 2024 and held it in 1 quarter. The position peaked at $21.9K in Q2 2024. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2024.

  • nVerses Capital reported no remaining Avanos Medical position as of Q3 2024 after selling out during the quarter.
  • nVerses Capital sold 1,100 Avanos Medical shares in Q3 2024, an estimated $21.9K.
  • nVerses Capital first reported a position in Avanos Medical in Q2 2024 and held it in 1 quarter.
  • nVerses Capital's Avanos Medical position peaked at $21.9K in Q2 2024.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.